Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 16 | 2023 | 328 | 2.450 |
Why?
|
| Graft Rejection | 8 | 2021 | 458 | 1.210 |
Why?
|
| Graft Survival | 3 | 2017 | 465 | 0.660 |
Why?
|
| Tissue and Organ Procurement | 3 | 2017 | 164 | 0.600 |
Why?
|
| Cardiac Catheterization | 4 | 2017 | 419 | 0.520 |
Why?
|
| HLA Antigens | 1 | 2014 | 82 | 0.510 |
Why?
|
| Tissue Donors | 2 | 2014 | 195 | 0.480 |
Why?
|
| Child, Preschool | 15 | 2023 | 3185 | 0.460 |
Why?
|
| Viremia | 1 | 2012 | 13 | 0.460 |
Why?
|
| BK Virus | 1 | 2012 | 17 | 0.450 |
Why?
|
| Isoxazoles | 1 | 2012 | 22 | 0.450 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 33 | 0.450 |
Why?
|
| Child | 18 | 2023 | 6400 | 0.430 |
Why?
|
| Infant | 12 | 2023 | 2891 | 0.400 |
Why?
|
| Ultrasonography, Doppler | 1 | 2010 | 57 | 0.390 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 481 | 0.370 |
Why?
|
| Kidney Diseases | 1 | 2012 | 307 | 0.360 |
Why?
|
| Heart Ventricles | 3 | 2017 | 738 | 0.340 |
Why?
|
| Echocardiography | 3 | 2021 | 515 | 0.330 |
Why?
|
| Ventricular Function | 3 | 2017 | 93 | 0.330 |
Why?
|
| Fontan Procedure | 2 | 2022 | 129 | 0.320 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2023 | 164 | 0.320 |
Why?
|
| Kidney | 1 | 2012 | 945 | 0.310 |
Why?
|
| Adolescent | 14 | 2023 | 8903 | 0.280 |
Why?
|
| Heart | 1 | 2010 | 850 | 0.270 |
Why?
|
| Myocardial Contraction | 2 | 2017 | 383 | 0.270 |
Why?
|
| Heart Failure | 3 | 2022 | 1179 | 0.260 |
Why?
|
| Heart-Assist Devices | 3 | 2017 | 221 | 0.250 |
Why?
|
| Ventricular Function, Right | 2 | 2017 | 103 | 0.250 |
Why?
|
| Pulmonary Valve | 1 | 2023 | 40 | 0.230 |
Why?
|
| Immunosuppressive Agents | 3 | 2017 | 515 | 0.230 |
Why?
|
| Infant, Newborn | 5 | 2023 | 2453 | 0.200 |
Why?
|
| Diarrhea | 1 | 2020 | 63 | 0.200 |
Why?
|
| Heart Defects, Congenital | 2 | 2017 | 596 | 0.190 |
Why?
|
| Retrospective Studies | 8 | 2021 | 7263 | 0.190 |
Why?
|
| Incidence | 4 | 2020 | 1581 | 0.180 |
Why?
|
| Pediatrics | 2 | 2020 | 341 | 0.180 |
Why?
|
| Stroke Volume | 2 | 2022 | 586 | 0.180 |
Why?
|
| Female | 15 | 2021 | 37990 | 0.170 |
Why?
|
| Ventricular Dysfunction | 1 | 2017 | 15 | 0.170 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2017 | 6 | 0.170 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2017 | 5 | 0.160 |
Why?
|
| Humans | 21 | 2023 | 68502 | 0.160 |
Why?
|
| Induction Chemotherapy | 1 | 2017 | 39 | 0.160 |
Why?
|
| Hepatitis | 1 | 2017 | 25 | 0.160 |
Why?
|
| Male | 15 | 2021 | 37252 | 0.160 |
Why?
|
| Ventricular Pressure | 1 | 2017 | 82 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 172 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 168 | 0.150 |
Why?
|
| Anesthesia, General | 1 | 2016 | 86 | 0.150 |
Why?
|
| Treatment Outcome | 7 | 2023 | 7026 | 0.150 |
Why?
|
| Coronary Vessels | 1 | 2018 | 313 | 0.150 |
Why?
|
| Sildenafil Citrate | 1 | 2015 | 23 | 0.140 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2015 | 25 | 0.140 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 323 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2023 | 3702 | 0.140 |
Why?
|
| Tacrolimus | 2 | 2017 | 127 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 277 | 0.140 |
Why?
|
| HLA-C Antigens | 1 | 2014 | 8 | 0.130 |
Why?
|
| HLA-DQ Antigens | 1 | 2014 | 19 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2017 | 2004 | 0.130 |
Why?
|
| Histocompatibility Testing | 1 | 2014 | 38 | 0.130 |
Why?
|
| Centrifugation | 1 | 2013 | 16 | 0.120 |
Why?
|
| Extracorporeal Circulation | 1 | 2013 | 26 | 0.120 |
Why?
|
| Magnetics | 1 | 2013 | 52 | 0.120 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2013 | 99 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 696 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2013 | 117 | 0.110 |
Why?
|
| Heart Valve Prosthesis | 1 | 2013 | 222 | 0.110 |
Why?
|
| Viral Load | 1 | 2012 | 127 | 0.110 |
Why?
|
| Survival Rate | 1 | 2014 | 1054 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 3256 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1615 | 0.100 |
Why?
|
| Registries | 1 | 2014 | 730 | 0.100 |
Why?
|
| South Carolina | 2 | 2014 | 2750 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2012 | 211 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 536 | 0.090 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2010 | 102 | 0.090 |
Why?
|
| Diastole | 2 | 2022 | 161 | 0.090 |
Why?
|
| Myocardium | 1 | 2015 | 1204 | 0.090 |
Why?
|
| Young Adult | 4 | 2016 | 5708 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 2264 | 0.080 |
Why?
|
| Time Factors | 4 | 2017 | 4650 | 0.080 |
Why?
|
| Risk Factors | 4 | 2018 | 5718 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1752 | 0.070 |
Why?
|
| Prosthesis Design | 2 | 2017 | 301 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2018 | 705 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 791 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2023 | 242 | 0.060 |
Why?
|
| Heart Valves | 1 | 2023 | 171 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2023 | 249 | 0.050 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2020 | 6 | 0.050 |
Why?
|
| Cryptosporidiosis | 1 | 2020 | 7 | 0.050 |
Why?
|
| Cryptosporidium | 1 | 2020 | 9 | 0.050 |
Why?
|
| Sapovirus | 1 | 2020 | 7 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2077 | 0.050 |
Why?
|
| Feces | 1 | 2020 | 88 | 0.050 |
Why?
|
| Norovirus | 1 | 2020 | 31 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 492 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2018 | 89 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2020 | 110 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1139 | 0.040 |
Why?
|
| Primary Graft Dysfunction | 1 | 2017 | 12 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 245 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 101 | 0.040 |
Why?
|
| Thymectomy | 1 | 2017 | 11 | 0.040 |
Why?
|
| Propensity Score | 1 | 2017 | 116 | 0.040 |
Why?
|
| Angiography | 1 | 2017 | 194 | 0.040 |
Why?
|
| Anesthetics | 1 | 2016 | 30 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 94 | 0.040 |
Why?
|
| Systole | 1 | 2016 | 149 | 0.040 |
Why?
|
| Sirolimus | 1 | 2017 | 118 | 0.040 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 123 | 0.040 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2015 | 4 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 567 | 0.040 |
Why?
|
| Dobutamine | 1 | 2015 | 25 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 219 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2017 | 275 | 0.040 |
Why?
|
| Adult | 3 | 2023 | 21373 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2015 | 238 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 329 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 681 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 621 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2013 | 33 | 0.030 |
Why?
|
| Sternotomy | 1 | 2013 | 18 | 0.030 |
Why?
|
| Histocompatibility | 1 | 2013 | 17 | 0.030 |
Why?
|
| United States | 2 | 2017 | 7333 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 538 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 2093 | 0.030 |
Why?
|
| Transplant Recipients | 1 | 2014 | 109 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1419 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 121 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1852 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 595 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2013 | 174 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2014 | 737 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 121 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1857 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 1593 | 0.030 |
Why?
|
| Equipment Design | 1 | 2013 | 500 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 1514 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2013 | 250 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2013 | 384 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1734 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2013 | 880 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2015 | 1447 | 0.020 |
Why?
|